A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for the first time, opening unprecedented opportunities for the vaccine industry.
General Catalyst raises $8 billion, with $750 million for health care bets
The venture capital giant General Catalyst has raised $8 billion in fresh capital, with $750 million set aside for health care investments as its acquisition
October 24, 2024